Gilead data on remdesivir
- Remdesivir associated with improvement in clinical recovery
- 74.4% of patients recovered by Day 14 vs 59% of patients receiving standard of care
- Data incudes trial analysis and retrospective cohort of patients
- Mortality rate was 7.6% at Day 14 vs 12.5% not taking it
The headline sounds a bit better than the details but it's still good news. I'd certainly be lining up for treatment with it if I had COVID-19.
